Artikel ; Online: Eculizumab for paroxysmal nocturnal haemoglobinuria
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-
catastrophic health expenditure in Nepalese patients
2023 Band 4
Abstract: Abstract Paroxysmal nocturnal hemoglobinuria (PNH) results from a mutation in the phosphatidylinositol glycan class-A gene which causes uncontrolled complement activation with resultant intravascular hemolysis and its sequelae. Eculizumab is a terminal ... ...
Abstract | Abstract Paroxysmal nocturnal hemoglobinuria (PNH) results from a mutation in the phosphatidylinositol glycan class-A gene which causes uncontrolled complement activation with resultant intravascular hemolysis and its sequelae. Eculizumab is a terminal complement inhibitor that blocks this complement activation and has revolutionized the treatment of PNH but comes with an enormous price which can have catastrophic health expenditure in low-middle income countries (LMIC) like Nepal. Here, we discuss the potential way forwards in the treatment of PNH in Nepal and other LMICs. |
---|---|
Schlagwörter | Catastrophic health expenditure ; Eculizumab ; Low and middle-income countries ; Orphan drug ; Paroxysmal nocturnal hemoglobinuria ; Nepal ; Medicine ; R |
Sprache | Englisch |
Erscheinungsdatum | 2023-06-01T00:00:00Z |
Verlag | BMC |
Dokumenttyp | Artikel ; Online |
Datenquelle | BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl) |
Volltext online
Zusatzmaterialien
Kategorien
Fernleihe an ZB MED
Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.